CD8A and infection: Recent studies showed a high level of SARS-CoV-2-specific CD4+ and CD8+ T cell activation and expansion in the majority of patients (~ 70–100%) recovering from COVID-19 infection or patients with active infection, consistent with an effective adaptive immune response against several viral epitopes from various proteins (S, M, N, nsps, ORFs...).